| Bethanidine | hsa00030 | Pentose phosphate pathway | 3.06E-04 | 3 | P60891, P51854, P37837 | PRPS1, TKTL1, TALDO1 | More | |
| Bethanidine | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | |
| Bethanidine | hsa00071 | Fatty acid degradation | 2.52E-02 | 3 | O75521, P11766, P33121 | ECI2, ADH5, ACSL1 | More | |
| Bethanidine | hsa00500 | Starch and sucrose metabolism | 1.07E-03 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | |
| Bethanidine | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | |
| Bethanidine | hsa00590 | Arachidonic acid metabolism | 2.95E-03 | 3 | P11712, P18054, P09960 | CYP2C9, ALOX12, LTA4H | More | |
| Bethanidine | hsa00591 | Linoleic acid metabolism | 1.58E-03 | 1 | P11712 | CYP2C9 | More | |
| Bethanidine | hsa00630 | Glyoxylate and dicarboxylate metabolism | 4.12E-03 | 2 | P40925, P15104 | MDH1, GLUL | More | |
| Bethanidine | hsa00730 | Thiamine metabolism | 8.96E-04 | 3 | Q9Y6K8, P05186, P24666 | AK5, ALPL, ACP1 | More | |
| Bethanidine | hsa00760 | Nicotinate and nicotinamide metabolism | 3.52E-02 | 1 | P21589 | NT5E | More | |
| Bethanidine | hsa00770 | Pantothenate and CoA biosynthesis | 5.15E-04 | 3 | O95498, O95497, Q9NRN7 | VNN2, VNN1, AASDHPPT | More | |
| Bethanidine | hsa00970 | Aminoacyl-tRNA biosynthesis | 2.77E-04 | 4 | O95363, P54136, P14868, Q15046 | FARS2, RARS1, DARS, KARS | More | |
| Bethanidine | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 1.45E-04 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | |
| Bethanidine | hsa00982 | Drug metabolism - cytochrome P450 | 1.45E-04 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | |
| Bethanidine | hsa01100 | Metabolic pathways | 3.52E-02 | 23 | P05089, O95455, P21953, P32320, P11766, P06280, Q16875, O43286, O43451, P05186, P24666, Q9HCC0, P33121, Q08477, P15907, Q9UNP4, P37837, P32321, Q9BPW9, Q9UHY7, P43490, P46976, P06737 | ARG1, TGDS, BCKDHB, CDA, ADH5, GLA, PFKFB3, B4GALT5, MGAM, ALPL, ACP1, MCCC2, ACSL1, CYP4F3, ST6GAL1, ST3GAL5, TALDO1, DCTD, DHRS9, ENOPH1, PBEF1, GYG1, PYGL | More | |
| Bethanidine | hsa01200 | Carbon metabolism | 4.32E-02 | 3 | P51854, P37837, P60891 | TKTL1, TALDO1, PRPS1 | More | |
| Bethanidine | hsa01230 | Biosynthesis of amino acids | 2.60E-02 | 3 | P51854, P60891, P37837 | TKTL1, PRPS1, TALDO1 | More | |
| Bethanidine | hsa02010 | ABC transporters | 4.93E-02 | 1 | Q8IZY2 | ABCA7 | More | |
| Bethanidine | hsa04014 | Ras signaling pathway | 1.60E-02 | 4 | P49767, P17252, Q14644, P0DP23 | VEGFC, PRKCA, RASA3, CALM1 | More | |
| Bethanidine | hsa04020 | Calcium signaling pathway | 8.12E-05 | 6 | P17252, Q93086, Q15746, P0DP23, P23634, P49767 | PRKCA, P2RX5, MYLK, CALM1, ATP2B4, VEGFC | More | |
| Bethanidine | hsa04022 | cGMP-PKG signaling pathway | 3.50E-02 | 3 | P23634, Q15746, P0DP23 | ATP2B4, MYLK, CALM1 | More | |
| Bethanidine | hsa04060 | Cytokine-cytokine receptor interaction | 4.71E-02 | 2 | P78552, O75509 | IL13RA1, TNFRSF21 | More | |
| Bethanidine | hsa04071 | Sphingolipid signaling pathway | 1.19E-02 | 4 | P21453, Q9H228, P01375, Q13362 | S1PR1, EDG8, TNF, PPP2R5C | More | |
| Bethanidine | hsa04072 | Phospholipase D signaling pathway | 9.70E-03 | 2 | Q92529, Q14344 | SHC3, GNA13 | More | |
| Bethanidine | hsa04080 | Neuroactive ligand-receptor interaction | 1.97E-02 | 5 | P28472, P21453, Q9H228, P21730, P07550 | GABRB3, S1PR1, EDG8, C5AR1, ADRB2 | More | |
| Bethanidine | hsa04120 | Ubiquitin mediated proteolysis | 3.44E-02 | 4 | Q14145, Q13042, P62837, Q15751 | KEAP1, CDC16, UBE2D2, HERC1 | More | |
| Bethanidine | hsa04150 | mTOR signaling pathway | 2.23E-02 | 3 | P42338, Q13322, P49841 | PIK3CB, GRB10, GSK3B | More | |
| Bethanidine | hsa04213 | Longevity regulating pathway - multiple species | 2.85E-02 | 2 | Q9Y4H2, Q13547 | IRS2, HDAC1 | More | |
| Bethanidine | hsa04217 | Necroptosis | 2.34E-02 | 4 | P01375, P48023, Q14765, Q99878 | TNF, FASLG, STAT4, H2AC14 | More | |
| Bethanidine | hsa04261 | Adrenergic signaling in cardiomyocytes | 2.43E-03 | 7 | P07550, P22694, P18848, Q13362, P0DP23, P17252, P23634 | ADRB2, PRKACB, ATF4, PPP2R5C, CALM1, PRKCA, ATP2B4 | More | |
| Bethanidine | hsa04270 | Vascular smooth muscle contraction | 1.50E-02 | 3 | Q15746, P17252, P0DP23 | MYLK, PRKCA, CALM1 | More | |
| Bethanidine | hsa04380 | Osteoclast differentiation | 4.80E-02 | 4 | P06239, P42338, P14778, Q8N149 | LCK, PIK3CB, IL1R1, LILRA2 | More | |
| Bethanidine | hsa04510 | Focal adhesion | 2.35E-02 | 4 | Q15746, P17252, Q13489, P49767 | MYLK, PRKCA, BIRC3, VEGFC | More | |
| Bethanidine | hsa04530 | Tight junction | 3.29E-02 | 3 | P16989, P56750, Q14247 | CSDA, CLDN17, CTTN | More | |
| Bethanidine | hsa04610 | Complement and coagulation cascades | 2.33E-03 | 1 | P0C0L4 | C4A | More | |
| Bethanidine | hsa04612 | Antigen processing and presentation | 1.07E-03 | 6 | Q14953, P26715, P26717, Q13241, P01732, P01375 | KIR2DS5, KLRC1, KLRC2, KLRD1, CD8A, TNF | More | |
| Bethanidine | hsa04613 | Neutrophil extracellular trap formation | 1.02E-04 | 8 | P11215, Q13547, Q93077, P58876, P62807, Q16778, O60814, P68431 | ITGAM, HDAC1, HIST1H2AC, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | |
| Bethanidine | hsa04621 | NOD-like receptor signaling pathway | 1.93E-02 | 8 | Q16539, P10599, Q9H1Y0, P43490, O00463, P01375, P09341, P12838 | MAPK14, TXN, ATG5, PBEF1, TRAF5, TNF, CXCL1, DEFA4 | More | |
| Bethanidine | hsa04650 | Natural killer cell mediated cytotoxicity | 5.05E-04 | 7 | P01375, P20963, Q13241, P26718, P26717, Q14953, P26715 | TNF, CD247, KLRD1, KLRK1, KLRC2, KIR2DS5, KLRC1 | More | |
| Bethanidine | hsa04657 | IL-17 signaling pathway | 7.22E-04 | 8 | O00463, Q16539, P49841, P09341, P19875, P14780, P80188, P01375 | TRAF5, MAPK14, GSK3B, CXCL1, CXCL2, MMP9, LCN2, TNF | More | |
| Bethanidine | hsa04659 | Th17 cell differentiation | 4.12E-02 | 4 | P06239, P14784, P14778, P07766 | LCK, IL2RB, IL1R1, CD3E | More | |
| Bethanidine | hsa04662 | B cell receptor signaling pathway | 7.25E-03 | 4 | P49841, P42338, P21854, Q8N149 | GSK3B, PIK3CB, CD72, LILRA2 | More | |
| Bethanidine | hsa04668 | TNF signaling pathway | 3.55E-02 | 4 | P01375, P18848, P19875, P14780 | TNF, ATF4, CXCL2, MMP9 | More | |
| Bethanidine | hsa04720 | Long-term potentiation | 3.63E-02 | 2 | P17252, P0DP23 | PRKCA, CALM1 | More | |
| Bethanidine | hsa04722 | Neurotrophin signaling pathway | 3.27E-02 | 3 | P49841, O43524, P48023 | GSK3B, FOXO3, FASLG | More | |
| Bethanidine | hsa04726 | Serotonergic synapse | 1.50E-02 | 3 | P17252, P11712, P18054 | PRKCA, CYP2C9, ALOX12 | More | |
| Bethanidine | hsa04730 | Long-term depression | 3.52E-02 | 1 | Q14344 | GNA13 | More | |
| Bethanidine | hsa04740 | Olfactory transduction | 2.52E-02 | 1 | Q9H255 | OR51E2 | More | |
| Bethanidine | hsa04742 | Taste transduction | 1.01E-02 | 1 | P30939 | HTR1F | More | |
| Bethanidine | hsa04750 | Inflammatory mediator regulation of TRP channels | 1.05E-03 | 6 | P14778, P18054, P42338, P17252, P24723, P0DP23 | IL1R1, ALOX12, PIK3CB, PRKCA, PRKCH, CALM1 | More | |
| Bethanidine | hsa04912 | GnRH signaling pathway | 3.63E-02 | 2 | P17252, P0DP23 | PRKCA, CALM1 | More | |
| Bethanidine | hsa04913 | Ovarian steroidogenesis | 2.54E-02 | 2 | P42330, P22694 | AKR1C3, PRKACB | More | |
| Bethanidine | hsa04916 | Melanogenesis | 3.97E-03 | 3 | P0DP23, Q9UJU2, P17252 | CALM1, LEF1, PRKCA | More | |
| Bethanidine | hsa04921 | Oxytocin signaling pathway | 2.19E-02 | 3 | Q15746, P0DP23, P17252 | MYLK, CALM1, PRKCA | More | |
| Bethanidine | hsa04924 | Renin secretion | 4.04E-02 | 2 | P22694, P07550 | PRKACB, ADRB2 | More | |
| Bethanidine | hsa04925 | Aldosterone synthesis and secretion | 5.51E-03 | 3 | P0DP23, P17252, P23634 | CALM1, PRKCA, ATP2B4 | More | |
| Bethanidine | hsa04926 | Relaxin signaling pathway | 2.41E-02 | 4 | P18848, P22694, P14780, P30679 | ATF4, PRKACB, MMP9, GNA15 | More | |
| Bethanidine | hsa04927 | Cortisol synthesis and secretion | 2.54E-02 | 2 | P18848, P22694 | ATF4, PRKACB | More | |
| Bethanidine | hsa04929 | GnRH secretion | 3.63E-02 | 2 | P42338, P49407 | PIK3CB, ARRB1 | More | |
| Bethanidine | hsa04932 | Non-alcoholic fatty liver disease | 2.74E-02 | 3 | P01375, P49841, P48023 | TNF, GSK3B, FASLG | More | |
| Bethanidine | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | |
| Bethanidine | hsa04960 | Aldosterone-regulated sodium reabsorption | 4.38E-02 | 1 | P48048 | KCNJ1 | More | |
| Bethanidine | hsa04961 | Endocrine and other factor-regulated calcium reabsorption | 1.40E-02 | 2 | P23634, P17252 | ATP2B4, PRKCA | More | |
| Bethanidine | hsa04964 | Proximal tubule bicarbonate reclamation | 4.93E-02 | 1 | P00918 | CA2 | More | |
| Bethanidine | hsa04966 | Collecting duct acid secretion | 4.93E-02 | 1 | P00918 | CA2 | More | |
| Bethanidine | hsa04970 | Salivary secretion | 2.29E-04 | 6 | P07550, P22694, P23634, P17252, P0DP23, P49913 | ADRB2, PRKACB, ATP2B4, PRKCA, CALM1, CAMP | More | |
| Bethanidine | hsa04971 | Gastric acid secretion | 5.51E-03 | 3 | P17252, P0DP23, Q15746 | PRKCA, CALM1, MYLK | More | |
| Bethanidine | hsa04972 | Pancreatic secretion | 1.40E-02 | 2 | P23634, P17252 | ATP2B4, PRKCA | More | |
| Bethanidine | hsa04973 | Carbohydrate digestion and absorption | 4.12E-03 | 2 | O43451, P42338 | MGAM, PIK3CB | More | |
| Bethanidine | hsa05031 | Amphetamine addiction | 4.32E-02 | 3 | P22694, P18848, Q13547 | PRKACB, ATF4, HDAC1 | More | |
| Bethanidine | hsa05034 | Alcoholism | 2.05E-05 | 7 | Q13547, Q93077, P58876, P62807, Q16778, O60814, P68431 | HDAC1, HIST1H2AC, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | |
| Bethanidine | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 2.27E-02 | 4 | Q16539, P09341, P25024, P25025 | MAPK14, CXCL1, CXCR1, CXCR2 | More | |
| Bethanidine | hsa05133 | Pertussis | 2.92E-03 | 3 | P0DP23, P09871, P0C0L4 | CALM1, C1S, C4A | More | |
| Bethanidine | hsa05140 | Leishmaniasis | 2.47E-02 | 5 | P13612, O75015, P01375, P49006, Q16539 | ITGA4, FCGR3B, TNF, MARCKSL1, MAPK14 | More | |
| Bethanidine | hsa05143 | African trypanosomiasis | 7.50E-04 | 4 | P01375, P69905, P68871, P48023 | TNF, HBA2, HBB, FASLG | More | |
| Bethanidine | hsa05144 | Malaria | 1.44E-03 | 5 | P69905, P68871, P01375, P35443, P26718 | HBA2, HBB, TNF, THBS4, KLRK1 | More | |
| Bethanidine | hsa05146 | Amoebiasis | 3.03E-03 | 8 | P09341, P19875, P14778, P27930, P01375, P05089, P30679, P22694 | CXCL1, CXCL2, IL1R1, IL1R2, TNF, ARG1, GNA15, PRKACB | More | |
| Bethanidine | hsa05160 | Hepatitis C | 1.27E-02 | 4 | P60033, P49841, P01375, P48023 | CD81, GSK3B, TNF, FASLG | More | |
| Bethanidine | hsa05163 | Human cytomegalovirus infection | 3.28E-02 | 7 | P01375, P50151, P49841, P14778, P25025, Q16539, O00463 | TNF, GNG10, GSK3B, IL1R1, CXCR2, MAPK14, TRAF5 | More | |
| Bethanidine | hsa05202 | Transcriptional misregulation in cancer | 1.24E-02 | 4 | P27930, P11215, Q13547, P12980 | IL1R2, ITGAM, HDAC1, LYL1 | More | |
| Bethanidine | hsa05203 | Viral carcinogenesis | 1.22E-03 | 6 | Q13547, Q15283, P58876, P62807, Q16778, O60814 | HDAC1, RASA2, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12 | More | |
| Bethanidine | hsa05204 | Chemical carcinogenesis | 4.09E-04 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | |
| Bethanidine | hsa05205 | Proteoglycans in cancer | 3.68E-02 | 5 | P14780, P01375, P23588, Q13635, P22694 | MMP9, TNF, EIF4B, PTCH1, PRKACB | More | |
| Bethanidine | hsa05214 | Glioma | 4.55E-02 | 2 | P0DP23, P17252 | CALM1, PRKCA | More | |
| Bethanidine | hsa05225 | Hepatocellular carcinoma | 1.85E-02 | 2 | Q92529, P51531 | SHC3, SMARCA2 | More | |
| Bethanidine | hsa05321 | Inflammatory bowel disease | 1.91E-02 | 3 | P01375, Q14765, Q9UL17 | TNF, STAT4, TBX21 | More | |
| Bethanidine | hsa05322 | Systemic lupus erythematosus | 4.80E-06 | 7 | P09871, Q93077, P58876, P62807, Q16778, O60814, P68431 | C1S, HIST1H2AC, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | |
| Bethanidine | hsa05330 | Allograft rejection | 2.72E-02 | 2 | P48023, P01375 | FASLG, TNF | More | |
| Bethanidine | hsa05332 | Graft-versus-host disease | 7.27E-04 | 4 | P48023, P01375, P26715, Q13241 | FASLG, TNF, KLRC1, KLRD1 | More | |
| Bethanidine | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.93E-02 | 1 | P54284 | CACNB3 | More | |
| Bethanidine | hsa05418 | Fluid shear stress and atherosclerosis | 2.43E-03 | 7 | Q16539, P42338, P10599, P14780, P01375, P14778, P27930 | MAPK14, PIK3CB, TXN, MMP9, TNF, IL1R1, IL1R2 | More | |
